Essential regulation of lung surfactant homeostasis by the orphan G protein-coupled receptor GPR116.

GPR116 is an orphan seven-pass transmembrane receptor whose function has been unclear. Global disruption of the Gpr116 gene in mice revealed an unexpected, critical role for this receptor in lung surfactant homeostasis, resulting in progressive accumulation of surfactant lipids and proteins in the alveolar space, labored breathing, and a reduced lifespan. GPR116 expression analysis, bone marrow transplantation studies, and characterization of conditional knockout mice revealed that GPR116 expression in ATII cells is required for maintaining normal surfactant levels. Aberrant packaging of surfactant proteins with lipids in the Gpr116 mutant mice resulted in compromised surfactant structure, function, uptake, and processing. Thus, GPR116 plays an indispensable role in lung surfactant homeostasis with important ramifications for the understanding and treatment of lung surfactant disorders.

[1]  J. Whitsett,et al.  Human GM-CSF autoantibodies and reproduction of pulmonary alveolar proteinosis. , 2009, The New England journal of medicine.

[2]  N. Copeland,et al.  A highly efficient recombineering-based method for generating conditional knockout mutations. , 2003, Genome research.

[3]  R. Epaud,et al.  Pulmonary alveolar proteinosis , 2011, European Respiratory Review.

[4]  B. Hogan,et al.  Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation , 2005, Development.

[5]  J. Heath,et al.  Alveolar Epithelial Type II Cells Induce T Cell Tolerance to Specific Antigen1 , 2008, The Journal of Immunology.

[6]  S. H. Rosen,et al.  Pulmonary alveolar proteinosis. , 1958, The New England journal of medicine.

[7]  A. Brody,et al.  Isolation and primary culture of murine alveolar type II cells. , 1996, American journal of respiratory cell and molecular biology.

[8]  J. Whitsett,et al.  Surfactant protein D influences surfactant ultrastructure and uptake by alveolar type II cells. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[9]  Dali Li,et al.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets , 2012, Acta Pharmacologica Sinica.

[10]  M. Miller,et al.  Normal surfactant pool sizes and inhibition-resistant surfactant from mice that overexpress surfactant protein A. , 1999, American journal of respiratory cell and molecular biology.

[11]  H. Brown,et al.  Quantitative analysis of glycerophospholipids by LC-MS: acquisition, data handling, and interpretation. , 2011, Biochimica et biophysica acta.

[12]  E. Larsson,et al.  Identification of a Core Set of 58 Gene Transcripts With Broad and Specific Expression in the Microvasculature , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[13]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[14]  J. Whitsett,et al.  GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1. , 2001, Immunity.

[15]  K. Raghavendran,et al.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome. , 2011, Critical care clinics.

[16]  V. Coppola,et al.  Gene targeting in mouse embryonic stem cells. , 2009, Methods in molecular biology.

[17]  J. Whitsett,et al.  Pulmonary alveolar proteinosis. , 2003, The New England journal of medicine.

[18]  A. Fisher,et al.  Identification of LBM180, a Lamellar Body Limiting Membrane Protein of Alveolar Type II Cells, as the ABC Transporter Protein ABCA3* , 2002, The Journal of Biological Chemistry.

[19]  W. J. Dyer,et al.  A rapid method of total lipid extraction and purification. , 1959, Canadian journal of biochemistry and physiology.

[20]  R. Veldhuizen,et al.  The future of surfactant therapy during ALI/ARDS. , 2006, Seminars in respiratory and critical care medicine.

[21]  B. Barna,et al.  Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice. , 2011, Biochemical and biophysical research communications.

[22]  S. Hirose,et al.  Ig-Hepta, a Novel Member of the G Protein-coupled Hepta-helical Receptor (GPCR) Family That Has Immunoglobulin-like Repeats in a Long N-terminal Extracellular Domain and Defines a New Subfamily of GPCRs* , 1999, The Journal of Biological Chemistry.

[23]  B. Barna,et al.  Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. , 2011, American journal of physiology. Lung cellular and molecular physiology.

[24]  L. Tessarollo,et al.  Manipulating mouse embryonic stem cells. , 2009, Methods in molecular biology.

[25]  J. Whitsett,et al.  Conditional expression of genes in the respiratory epithelium in transgenic mice: cautionary notes and toward building a better mouse trap. , 2009, American journal of respiratory cell and molecular biology.

[26]  K. Kinzler,et al.  TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI) , 2004, Cancer Research.

[27]  Barry H. Smith,et al.  A continuous tumor‐cell line from a human lung carcinoma with properties of type II alveolar epithelial cells , 1976, International journal of cancer.

[28]  K. Drickamer,et al.  The major lung surfactant protein, SP 28-36, is a calcium-dependent, carbohydrate-binding protein. , 1987, The Journal of biological chemistry.

[29]  B. Trapnell,et al.  The molecular basis of pulmonary alveolar proteinosis. , 2010, Clinical immunology.

[30]  S. Seaman,et al.  Genes that distinguish physiological and pathological angiogenesis. , 2007, Cancer cell.

[31]  L. Jeannotte,et al.  Unsuspected effects of a lung‐specific cre deleter mouse line , 2011, Genesis.

[32]  Raphael Kopan,et al.  rtTA toxicity limits the usefulness of the SP-C-rtTA transgenic mouse. , 2009, Developmental biology.

[33]  H. Brown,et al.  Glycerophospholipid identification and quantitation by electrospray ionization mass spectrometry. , 2007, Methods in enzymology.